SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?


To: pincus who wrote (12918)6/2/2014 8:01:29 PM
From: CharlestonBuckeye  Respond to of 13111
 
confirms these past four years have been a waste. Keep kicking the can Dees, keep kicking the can.....



To: pincus who wrote (12918)6/3/2014 9:36:52 AM
From: Jack Russell  Read Replies (2) | Respond to of 13111
 
Briefing.com - tumors were not longer detectable (complete response)



  • 8:26 am Provectus Pharma:PV-10 data presented at the American Society of Clinical Oncology annual meeting; In the phase 2 PV-10 trial, when all existing lesions were injected with PV-10, tumors were no longer detectable (complete response) at Briefing.com Tue 8:26am